Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

No support for association between the dopamine transporter (DAT1) gene and ADHD.

Langley K, Turic D, Peirce TR, Mills S, Van Den Bree MB, Owen MJ, O'Donovan MC, Thapar A.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):7-10.

PMID:
16082688
2.

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M.

Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):50-4.

PMID:
12898575
3.
4.
5.

Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.

Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, Nöthen MM, Grünhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL.

Biol Psychiatry. 2001 Feb 15;49(4):333-9.

PMID:
11239904
6.
7.

A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.

Genro JP, Polanczyk GV, Zeni C, Oliveira AS, Roman T, Rohde LA, Hutz MH.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1568-75. doi: 10.1002/ajmg.b.30863.

PMID:
18802919
8.

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):233-9. doi: 10.1089/cap.2008.0133.

9.

Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.

Bellgrove MA, Barry E, Johnson KA, Cox M, Dáibhis A, Daly M, Hawi Z, Lambert D, Fitzgerald M, McNicholas F, Robertson IH, Gill M, Kirley A.

Neuropsychopharmacology. 2008 Sep;33(10):2536-45. Epub 2007 Nov 28.

10.

An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.

Tong JH, Cummins TD, Johnson BP, McKinley LA, Pickering HE, Fanning P, Stefanac NR, Newman DP, Hawi Z, Bellgrove MA.

Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):89-96. doi: 10.1002/ajmg.b.32283. Epub 2015 Feb 5.

PMID:
25656223
11.

Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).

Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):1-6.

PMID:
16082693
12.

Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Bédard AC, Schulz KP, Cook EH Jr, Fan J, Clerkin SM, Ivanov I, Halperin JM, Newcorn JH.

Neuroimage. 2010 Nov 15;53(3):935-42. doi: 10.1016/j.neuroimage.2009.12.041. Epub 2009 Dec 21.

13.

Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.

Shang CY, Gau SS, Liu CM, Hwu HG.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):421-8. doi: 10.1016/j.pnpbp.2010.08.016. Epub 2010 Aug 26.

PMID:
20800641
14.
15.

Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.

de Azeredo LA, Rovaris DL, Mota NR, Polina ER, Marques FZ, Contini V, Vitola ES, Belmonte-de-Abreu P, Rohde LA, Grevet EH, Bau CH.

Eur Arch Psychiatry Clin Neurosci. 2014 Aug;264(5):401-8. doi: 10.1007/s00406-014-0486-8. Epub 2014 Feb 1. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2016 Oct 17;:.

PMID:
24487615
16.

A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.

Šerý O, Paclt I, Drtílková I, Theiner P, Kopečková M, Zvolský P, Balcar VJ.

Behav Brain Funct. 2015 Jun 11;11:21. doi: 10.1186/s12993-015-0066-8.

17.

Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.

Ohadi M, Shirazi E, Tehranidoosti M, Moghimi N, Keikhaee MR, Ehssani S, Aghajani A, Najmabadi H.

Brain Res. 2006 Jul 26;1101(1):1-4. Epub 2006 Jun 19.

PMID:
16782077
18.

Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.

Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.

Arch Gen Psychiatry. 2007 May;64(5):585-90.

PMID:
17485610
19.

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.

Mick E, Biederman J, Spencer T, Faraone SV, Sklar P.

Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):890-4.

20.

Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.

Lim MH, Kim HW, Paik KC, Cho SC, Yoon DY, Lee HJ.

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):309-11.

PMID:
16526026

Supplemental Content

Support Center